Thereby, the qualitative findings on an enhanced immunosignal for MBP at 24 h after experimental stroke were robustly confirmed by quantitative analyses with a maximum of reaction in the ischemic core and a declining course toward more peripheral areas. The gene discussed is MBP; the disease is stroke disorder.